145 trends tracked about this subject — the full history, oldest to newest below.
DJ Khaled publicly details a 75-to-90-pound weight loss aided by GLP-1 medication Wegovy, sparking wide entertainment-media coverage.
Valerie Bertinelli, 66, shared an Instagram video showing her weight loss in flared jeans and a sweater, prompting fans to say she looks 15 years younger.
Metabolic walking is trending as a low-impact strategy for building lean muscle and supporting weight loss, with three major health outlets publishing dedicated coverage on November 11, 2026.
A major study indicates a powerful new weight-loss drug may also ease knee pain, according to recent coverage.
New research suggests popular GLP-1 weight-loss medications may influence brain health, prompting medical debate over expanding their use beyond diabetes and obesity.
Experimental drug retatrutide cut knee osteoarthritis pain by half for nearly 70% of patients across two clinical trials while also reducing body weight.
The FDA is requiring all GLP-1 drug makers to add warnings about a possible increased risk of NAION, a rare eye condition that can cause sudden and permanent vision loss.
Hims & Hers Health reported Q3 2026 revenue of $401.6 million, up 69% year over year, but narrowed its full-year revenue guidance and cut its adjusted EBITDA forecast, sending shares down sharply.
A small Adelaide University sheep study found a single dose of semaglutide cut maternal cardiac output and fetal oxygen levels within two hours, raising new questions about GLP-1 drug safety during pregnancy.
A 40-week study found that resistance training helped people taking tirzepatide lose 25% less lean tissue while improving strength by 10%.
Insurers are cutting coverage for GLP-1 weight-loss drugs, with coverage dropping from 57% to 53% between 2025 and 2026, while list prices range from $500 to over $1,000 monthly.
Recent reporting examines the challenges of weight maintenance and patient adherence after stopping GLP-1 medications.
Recent studies explore daily coffee consumption habits, focusing on weight management and healthy blood pressure levels.
A new study found that 54% of younger adults with early-onset type 2 diabetes achieved remission after six months of an intensive diet and exercise program.
2 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
Actor John Goodman reflects on his dramatic weight loss transformation, describing his physical changes and the ongoing adjustment to his appearance.
Actor John Goodman reflects on the physical and psychological challenges following a 200 lb weight loss transformation.
Recent coverage examines nutritional deficiencies linked to weight-loss injections and highlights the importance of protein intake.
Ricki Lake reveals Rosie O'Donnell's initial judgment regarding her facelift before O'Donnell pursued one herself.
Former American Idol runner-up Bo Bice has unveiled a drastic physical transformation, including an 89-pound weight loss and a new short haircut.
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Coverage explores unexpected side effects, mental health impacts, and generational patterns surrounding GLP-1 medications.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
An experimental weight-loss drug named Retatrutide is making news for potentially improving sleep apnea symptoms.
Eli Lilly reports that its new drug, retatrutide, achieved more than double the weight loss of Ozempic's highest approved dose in a head-to-head trial.
New research suggests a synergy between hormone therapy and GLP-1 weight-loss medications for women navigating menopause.
Recent reporting explores the physical, neurological, and weight loss impacts of cutting back or quitting alcohol entirely.
An investigational triple-action weekly weight-loss drug significantly reduces obstructive sleep apnea severity in late-stage clinical trials.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent research indicates that losing weight in middle age can significantly improve or restore cardiovascular health.
Actor John Goodman discusses his historic 200-pound weight loss and past struggles with food and alcohol.
7 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A landmark two-year study challenges long-held assumptions about diet soda and its impact on weight loss.
Unapproved weight loss drug retatrutide faces a booming black market linked to multiple reported deaths and severe side effects.
7 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
Recent coverage examines what happens when individuals stop taking GLP-1 weight loss and diabetes medications.
Recent research reveals diet soda drinkers lost just as much weight as water drinkers over a two-year period.
Recent scientific findings point to potential methods for limiting weight regain after patients stop taking GLP-1 medications.
Recent coverage examines the rising use of GLP-1 medications among children, highlighting strong weight loss alongside nutritional and data gaps.
15 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Ongoing legal actions and international reports highlight severe risks linked to weight-loss drugs.
14 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A major clinical trial suggests that diet drinks may be as effective as water for weight loss, challenging common dietary assumptions.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent studies link popular GLP-1 weight-loss drugs to surprising physical side effects including hair loss and nail troubles.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
15 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent studies link weight-loss medications like Ozempic and Wegovy to unexpected hair and nail side effects.
An experimental combination drug from Eli Lilly outperforms Zepbound in a new weight-loss trial.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A major two-year trial from the University of Liverpool suggests diet drinks match water for long-term weight loss and management.
Certified trainers and professional bodybuilders showcase structured walking routines targeting visceral fat and weight loss.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
GLP-1 medications are shifting from clinical obesity treatments for patients to lifestyle products for customers, amid a surge in oral pill options.